Mike Polark
Stock Analyst at Wolfe Research
(3.29)
# 1,064
Out of 4,479 analysts
63
Total ratings
51.35%
Success rate
1.81%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Upgrades: Outperform | $115 | $98.61 | +16.62% | 5 | Jun 20, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $197.19 | +1.43% | 2 | May 7, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $58 → $66 | $52.89 | +24.79% | 6 | May 2, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $440 → $436 | $438.81 | -0.64% | 5 | Apr 19, 2024 | |
| NVRO Nevro | Maintains: Neutral | $23 → $19 | $8.35 | +127.54% | 7 | Feb 22, 2024 | |
| AXNX Axonics | Downgrades: Peer Perform | n/a | $67.45 | - | 3 | Jan 9, 2024 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $57 | $91.23 | -37.52% | 2 | Nov 28, 2023 | |
| SILK Silk Road Medical | Upgrades: Peer Perform | n/a | $27.02 | - | 4 | Oct 24, 2023 | |
| RMD ResMed | Downgrades: Peer Perform | n/a | $189.35 | - | 4 | Sep 29, 2023 | |
| ABT Abbott Laboratories | Upgrades: Peer Perform | n/a | $103.20 | - | 3 | Jul 21, 2023 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $371 | $134.25 | +176.35% | 3 | Jul 19, 2023 | |
| TFX Teleflex | Downgrades: Peer Perform | n/a | $211.25 | - | 3 | Apr 26, 2023 | |
| DXCM DexCom | Initiates: Outperform | $121 | $112.49 | +7.57% | 1 | Jan 26, 2023 | |
| TNDM Tandem Diabetes Care | Initiates: Peer Perform | n/a | $39.15 | - | 1 | Jan 26, 2023 | |
| SHC Sotera Health Company | Upgrades: Outperform | $25 | $11.63 | +114.96% | 4 | Jan 11, 2023 | |
| MASI Masimo | Upgrades: Outperform | $165 | $113.42 | +45.48% | 3 | Sep 15, 2022 | |
| BSX Boston Scientific | Initiates: Outperform | n/a | $76.55 | - | 1 | Jul 6, 2022 | |
| MDT Medtronic | Initiates: Underperform | n/a | $77.37 | - | 1 | Jul 6, 2022 | |
| NPCE NeuroPace | Initiates: Outperform | $13 | $7.23 | +79.81% | 2 | Apr 6, 2022 | |
| NYXH Nyxoah | Initiates: Peer Perform | $21 | $7.02 | +199.15% | 1 | Apr 6, 2022 | |
| STE STERIS | Maintains: Outperform | n/a | $218.34 | - | 1 | Aug 11, 2021 | |
| BEAT HeartBeam | Initiates: Neutral | n/a | $2.95 | - | 1 | Sep 2, 2020 |
iRhythm Technologies
Jun 20, 2024
Upgrades: Outperform
Price Target: $115
Current: $98.61
Upside: +16.62%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $197.19
Upside: +1.43%
LivaNova
May 2, 2024
Maintains: Neutral
Price Target: $58 → $66
Current: $52.89
Upside: +24.79%
Intuitive Surgical
Apr 19, 2024
Maintains: Outperform
Price Target: $440 → $436
Current: $438.81
Upside: -0.64%
Nevro
Feb 22, 2024
Maintains: Neutral
Price Target: $23 → $19
Current: $8.35
Upside: +127.54%
Axonics
Jan 9, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $67.45
Upside: -
Edwards Lifesciences
Nov 28, 2023
Downgrades: Underperform
Price Target: $57
Current: $91.23
Upside: -37.52%
Silk Road Medical
Oct 24, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $27.02
Upside: -
ResMed
Sep 29, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $189.35
Upside: -
Abbott Laboratories
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $103.20
Upside: -
Inspire Medical Systems
Jul 19, 2023
Initiates: Outperform
Price Target: $371
Current: $134.25
Upside: +176.35%
Teleflex
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $211.25
Upside: -
DexCom
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $112.49
Upside: +7.57%
Tandem Diabetes Care
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $39.15
Upside: -
Sotera Health Company
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $11.63
Upside: +114.96%
Masimo
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $113.42
Upside: +45.48%
Boston Scientific
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $76.55
Upside: -
Medtronic
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $77.37
Upside: -
NeuroPace
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $7.23
Upside: +79.81%
Nyxoah
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $7.02
Upside: +199.15%
STERIS
Aug 11, 2021
Maintains: Outperform
Price Target: n/a
Current: $218.34
Upside: -
HeartBeam
Sep 2, 2020
Initiates: Neutral
Price Target: n/a
Current: $2.95
Upside: -